High-resolution microendoscopy (HRME) is a low-cost, " optical biopsy " technology that allows for subcellular imaging. The purpose of this study was to determine the in vivo diagnostic accuracy of the HRME for the differentiation of neoplastic from non-neoplastic colorectal polyps and compare it to that of high-defi nition white-light endoscopy (WLE) with histopathology as the gold standard.
INTRODUCTION
Advances in colorectal screening programs and colonoscopy technology have resulted in signifi cant decreases in colorectal cancer incidence and mortality ( 1 -3 ) . However, colorectal cancer remains the third most common cancer in the United States and is the second most common cause of cancer-related deaths ( 4, 5 ) . Colonoscopy screening focuses on the early and accurate detection of adenomas, neoplastic polyps with malignant potential. Unfortunately, the appearance of these neoplastic adenomas is not visibly distinct compared with their non-neoplastic polyp counterparts on white-light endoscopy (WLE). Th erefore, the current gold standard for diagnosis entails removal of virtually all visualized polyps, followed by formal histopathologic analysis ( 6 ) . Given the fact that the majority of visualized lesions are non-neoplastic and less than half of all resected polyps are neoplastic, the current gold standard results in excess polypectomies and histology costs ( 7, 8 ) . Hassan et al. showed reducing the number of polyps requiring formal histopathologic analysis would signifi cantly enhance cost-eff ectiveness of the screening colonoscopy ( 9 ) . Th erefore, a tool that allowed the endoscopist In Vivo Diagnostic Accuracy of High-Resolution Microendoscopy in Differentiating Neoplastic from Non-Neoplastic Colorectal Polyps: A Prospective Study to make an in vivo classifi cation of colorectal neoplasia could signifi cantly reduce overall costs and diminish the patient risks of unnecessary polypectomies.
Various technologies have been developed to improve the ability of WLE at classifying neoplastic from non-neoplastic polyps and, therefore, allow for a more selective biopsy approach. Dyebased chromoendoscopy showed moderate success with colorectal dysplasia detection, especially in patients with ulcerative colitis but the procedure is cumbersome ( 10 -15 ) . Although digital chromoendoscopy such as narrow band imaging (NBI) has shown promise with sensitivities greater than 90 % at diagnosing colorectal neoplasia, specifi city has been much lower and overall, results have been mixed in terms of diagnostic accuracy ( 16 -22 ) . And although confocal laser endomicroscopy (CLE) platforms have been the most promising as complementary tools to white-light colonoscopy with sensitivity and specifi city as high as 97 % , their widespread use has been limited by their high cost and need for intravenous contrast ( 23 -28 ) .
High-resolution microendoscopy (HRME) is a low-cost, highresolution imaging tool consisting of a 1-mm diameter fi ber-optic bundle that allows for subcellular imaging at × 1,000 magnifi cation at 4 μ m resolution. HRME was fi rst described by Muldoon et al. and has already been found to be eff ective in detecting other gastrointestinal diseases ( 29 -33 ) . Chang et al. developed a classification system for HRME to diff erentiate neoplastic from non-neoplastic colorectal polyps and aft er viewing a brief training set, both expert and novice endoscopists could identify neoplastic polyps with high specifi city and inter-observer agreement ( 34 ) .
Given that HRME is both inexpensive (equipment cost is less than $ 2000) and can be learned quickly, it has the potential to be an eff ective complementary imaging tool to WLE. Th e primary aim of this trial was to evaluate the in vivo diagnostic accuracy of HRME for diff erentiating neoplastic (adenomatous, cancer) from non-neoplastic (normal, hyperplastic, infl ammatory) colorectal polyps and compare it to that of standard, high-defi nition WLE with histopathology as the gold standard.
METHODS

Study design and patient selection
Th e study was approved by the Institutional Review Boards at the Icahn School of Medicine at Mount Sinai and at Rice University and all patients signed informed consent before enrolling. It was a prospective cohort trial conducted at one tertiary care center and the study design met the recommendations of the STARD checklist for studies of diagnostic accuracy ( 35 ) . One hundred and forty-fi ve consecutive patients undergoing routine, scheduled screening or surveillance colonoscopies were enrolled. Patients were included if they were scheduled for a colonoscopy for screening or routine polyp surveillance, willing to sign informed consent, and able to complete a telephone follow-up call post-procedure. Exclusion criteria were an unhealthy or unfi t patient for standard colonoscopy or one who was unwilling to sign informed consent. Recruitment into the trial was based on the presence of at least one colorectal polyp that would be resected and undergo formal histopathologic analysis. Of the 145 patients enrolled, 94 had visible polyps, which were included in the analysis.
HRME
Th e description and technical specifi cations of the high-resolution microendoscope were previously described in detail by Muldoon et al. and Pierce et al. ( 31, 36 ) . Briefl y, the HRME unit comprises of a charge-coupled camera device, a fl exible imaging probe, and a topical contrast agent. Th e imaging probe is a 1-mm diameter fi beroptic bundle that is passed through the biopsy channel or accessory port of any standard colonoscope. Th is fi ber-optic imaging probe contains 30,000 optical fi bers with light-emitting diode (LED) illumination. Th e LED illumination is powered by the charge-coupled camera device and is transmitted via the imaging probe onto the mucosal surface. Once the mucosal surface has been sprayed by profl avine, a fl uorescent agent, the tissue refl ects fl uorescence in response to the LED illumination. Th e refl ected fl uorescence is captured via the imaging probe to the charge-coupled camera device that then transmits real-time HRME images onto the attached computer. In essence, HRME functions as a battery-powered fl uorescence microscope like that of confocal endomicroscopy, allows visualization of the mucosa at a × 1,000 magnifi cation. HRME provides a 720-μ m fi eld of view and 4.4-μ m spatial resolution. Th e cost of the charge-coupled camera device is approximately $ 1,500, whereas each probe costs approximately $ 300. Th e probe needs to be polished, and occasionally replaced, every 75 -80 patients.
Training in the HRME colon classifi cation system
Th ree endoscopists (SA, BS, YY) performed both HRME and standard colonoscopy on all the patients. SA was an advanced endoscopist with expertise in endoscopic imaging including endoscopic ultrasound and confocal laser endomicroscopy. BS and YY were both general gastroenterologists. All three had no prior training in HRME for colon imaging before study initiation. Before patient enrollment, all three endoscopists viewed a 5-min training set that consisted of 10 HRME images and explained the various features of the HRME colon classifi cation system ( 34 ) . Th is classifi cation system was developed by Chang et al. in conjunction with two expert gastrointestinal pathologists and is based on glandular morphology, epithelial thickness, and nuclear arrangement. Th e HRME criteria were established based on the World Health Organization histopathologic criteria for each category of colorectal polyps: normal colonic mucosa, hyperplastic polyp, tubular adenoma, tubulovillous adenoma, and adenocarcinoma ( 37 ) . An HRME read of " non-neoplastic " was assigned to classifi cation patterns for normal colonic mucosa, infl ammatory, or hyperplastic polyps ( Figure 1 ). An HRME read of " neoplastic " included tubular adenoma, tubulovillous adenoma, and adenocarcinoma. Aft er the training set was completed, the three endoscopists imaged 40 polyps in vivo using the HRME to gain competency before patient accrual began for this trial.
Performing the colonoscopy with HRME
In this trial, high-definition WLE (Olympus SIFQ80) was first performed to detect colonic polyps ( 31, 36 ) . Upon detection of a colonic polyp, the endoscopist would make a WLE diagnosis of non-neoplastic (normal, hyperplastic, or inflammatory) or neoplastic (adenoma or cancer). Once the WLE read was recorded, 1 -4 ml of proflavine dye (0.01 % ) was sprayed onto the mucosal surface of the polyp via an endoscopic spray catheter. Proflavine is a fluorescent topical antiseptic that highlights cell nuclei and was used in the study as an investigational drug under the FDA IND 102,217. After the proflavine was applied topically, the HRME probe was inserted through the biopsy port of the colonoscope and the fiber-optic tip was positioned directly onto the surface of the polyp. Once the probe was on the polyp, images were displayed on the system laptop at a rate of 12 frames per second. The average time required to spray the proflavine dye, place the probe onto the polyp, and make the optical diagnosis ranged from 50 to 80 s per polyp. This time included the occasional need for multiple HRME images to make a diagnosis. Using the colon HRME classification system, the endoscopist made the in-vivo optical diagnosis of neoplastic or non-neoplastic. All WLE and HRME reads had to be categorized as neoplastic or non-neoplastic; indeterminate reads were not acceptable. The imaged polyps were then removed by forceps or snare polypectomy and sent for formal histopathology analysis as per standard of care. Before polypectomy, when possible, the endoscopist visually estimated the size of the polyp in millimeters as compared with the maximum jaw opening of a standard, large-capacity biopsy forceps (8.6 mm).
Reference standard
A single expert gastrointestinal pathologist (AP) who was blinded to both the WLE and HRME diagnoses made the fi nal diagnosis of non-neoplastic (normal, hyperplastic, infl ammatory) or neoplastic (adenomatous, cancer) colorectal polyp, which served as the gold standard diagnosis for comparison.
Statistical analysis
Log binomial regression models were used to estimate the various measures of performance, viz., sensitivity, specifi city, positive predictive value (PPV), negative predictive value (NPV), and accuracy ( 38 ) . Accuracy in this study was defi ned as the percentage of time that the diagnostic test (HRME) agreed with the gold standard (histology). Th ese models account for the correlation among multiple biopsies on the same patient ( 39 ) . Interaction terms were included to assess whether the performance measures diff ered between the modalities of HRME and WLE. Th e analyses were carried out using PROC GENMOD in SAS. Th e sample size was calculated post hoc based on the fact that with n = 171 and a postulated value for sensitivity or specifi city of at least 80 % , this sample size was guaranteed to estimate the accuracy parameter with a precision (95 % confi dence interval) of ± 6 % .
RESULTS
Patient characteristics
A total of 145 patients was consented for the trial from September 2010 to April 2013. Of these, 94 patients (64.8 % ) had at least one visible colorectal polyp and were included in the fi nal analysis. Patient demographics are detailed in Table 1 . Eighty percent of patients were undergoing a screening colonoscopy while twenty percent of patients had a history of polyps and were undergoing surveillance colonoscopy. Almost 9 % had a history of colorectal cancer. Forty-eight patients (51.1 % ) had one polyp, twenty-eight patients (29.8 % ) had two polyps, thirteen patients (13.8 % ) had three polyps, and fi ve patients (5.3 % ) had more than three polyps. No patient reported any adverse events.
Polyp characteristics
A total of 171 polyps was detected by WLE, imaged by HRME, and evaluated histologically. Th e average size of the polyps 
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Accuracy of HRME in Differentiating Colon Polyps was 7.6 mm. Forty-fi ve percent ( n = 77) were neoplastic, with the majority being tubular adenomas. Of the non-neoplastic lesions, 52 % were hyperplastic. Table 2 details the polyp characteristics. Table 3 describes the performance characteristics of HRME in diff erentiating neoplastic from non-neoplastic colorectal polyps compared with WLE for all 171 polyps. Although sensitivity for neoplasia is not diff erent between the two modalities, HRME has a signifi cantly higher specifi city and accuracy compared with WLE. Th e PPV of HRME is also signifi cantly greater than that of WLE, whereas the NPV is not statistically diff erent. 
HRME and WLE performance characteristics of all polyps
HRME and WLE performance characteristics of small and diminutive polyps
Tables 4 and 5 describe the performance characteristics of HRME compared with WLE for small and diminutive polyps. Small polyps were defi ned as polyps estimated to be less than or equal to 10 mm. Diminutive polyps were defi ned as polyps estimated to be less than or equal to 5 mm. Although sensitivity is not diff erent between the two modalities, HRME has a signifi cantly higher specifi city and was not only signifi cantly greater than that of white light (39 % ) in our study but also greater than the 71 -78 % seen in pCLE studies and the 80 -85 % seen in NBI studies. It was the consistently low specifi city of NBI that eventually led to the development of CLE platforms and our study shows that HRME is more specifi c than either modality. Although HRME ' s sensitivity for neoplastic polyps at 94 % did not diff er signifi cantly from white light at 97 % in our study, it was greater than the 57 -91 % seen in pCLE trials and similar to that of dye-based chromoendoscopy and NBI. Th e endoscope-based CLE platform was the only modality to demonstrate similar performance characteristics to HRME ( 23, 24, 40 ) . However, most of the endoscope-based confocal laser endomicroscopy (eCLE) trials had fewer than 50 patients and the CLE image analysis and diagnosis were not conducted in vivo . Although both CLE and HRME provide subcellular imaging of the colorectal mucosa at × 1,000 magnifi cation, HRME costs more than one hundred and fi ft y thousand dollars less can be passed through any standard endoscope and does not require intravenous contrast. As large lesions have greater neoplastic potential and are invariably likely to be resected, the true benefi t of an in vivo classifi cation tool would be its ability to diff erentiate small lesions into neoplastic or non-neoplastic. More than 90 % of lesions smaller than 10 mm carry a very low risk of malignancy ( 8,41 -44 ) . Th us, a modality that could accurately classify these small lesions would allow the endoscopist to selectively determine which lesions could be left in situ , which lesions could be resected and discarded, and which lesions needed formal histopathologic analysis. Our study demonstrated accuracy of 95 % for small neoplastic lesions (less than or equal to 10 mm) and diminutive neoplastic lesions (less than or equal to 5 mm), both values were signifi cantly greater than the accuracies found on WLE. Specifi city of HRME for neoplasia was 98 % for small polyps and 98 % for diminutive polyps, again signifi cantly higher than white light. Th e NPV of HRME was 91 % for small polyps and 92 % for diminutive polyps. Sensitivity for neoplasia was above 93 % for all lesion sizes and was not signifi cantly diff erent than white light. Th e high accuracy of HRME, along with its high specifi city and high NPV for neoplasia in small and diminutive polyps, may allow the endoscopist to make enhanced, confi dent real-time decisions regarding leaving small, non-neoplastic polyps in situ and discarding small polyps with low neoplastic potential. In 2011, the American Society of Gastrointestinal Endoscopy issued a statement that in order for a new technology to guide the decision of either resecting and discarding or not resecting and leaving in situ diminutive and suspected non-neoplastic polyps, it must demonstrate a greater than 90 % NPV for adenomatous histology ( 45 ) . HRME fulfi lls this requirement and would allow the endoscopist to confi dently either resect and discard diminutive polyps or leave hyperplastic polyps unresected in situ . Th erefore, HRME could reduce time, number of polypectomies, and cost of histology.
Our prospective study had several notable strengths. Most importantly, our study was a true real-time, in vivo assessment of diagnostic abilities of HRME. Prior CLE studies used " offl ine " or post-hoc analysis of CLE images acquired during the colonoscopy. When images are analyzed offl ine, the endoscopist has the accuracy compared with WLE for the diff erentiation of both small and diminutive neoplastic polyps. Similarly, PPV is signifi cantly greater in HRME for both small and diminutive polyps, whereas there is no statistical diff erence in PPV compared with WLE for either polyp size.
DISCUSSION
Th is is the fi rst real-time, in vivo study prospectively assessing the diagnostic accuracy of HRME in diff erentiating neoplastic from non-neoplastic colorectal polyps. Th e trial demonstrated that HRME, with the use of a topical contrast agent, can eff ectively provide subcellular images of colorectal polyps; these images can be interpreted in real-time as neoplastic or non-neoplastic based on the colon HRME classifi cation system. Profl avine, the topical contrast agent used, was also tolerated safely by all study patients and no adverse events were reported. With histopathology as the gold standard for diagnosis, this study showed that HRME had 94 % sensitivity and 95 % specifi city for the diff erentiation of neoplastic from non-neoplastic colorectal polyps. Compared with high-defi nition WLE, HRME was signifi cantly more accurate (94 % vs. 65 % ) and demonstrated a signifi cantly greater specifi city (95 % vs. 39 % ) and PPV (87 % vs. 55 % ) for colorectal neoplasia.
Given the inability of WLE to classify neoplastic from non-neoplastic colorectal polyps, multiple modalities have been developed over the past decade to assist in this diff erentiation. Our study demonstrates that the overall performance characteristics of HRME are at least comparable to those of these other imaging modalities ( Table 6 ) . Th e accuracy of HRME in diff erentiating neoplastic from non-neoplastic colorectal polyps was 94 % , which was signifi cantly greater than the 65 % for high-defi nition WLE in our study. Th e 94 % accuracy of HRME was also an improvement over the 82 % seen in NBI and the 66 -82 % seen in probe-based confocal laser endomicroscopy (pCLE) . Any potential modality being developed to reduce the need for polypectomies and formal histopathology must have both high accuracy and high specifi city for neoplastic lesions such that the endoscopist can be confi dent with either leaving the non-neoplastic polyp in situ or simply discarding the lesion. Th e specifi city of HRME for neoplasia (95 % ) 
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Accuracy of HRME in Differentiating Colon Polyps advantage of long, careful inspection of the images, which is not feasible during an actual colonoscopy. When pCLE images were read in real-time during colonoscopy and compared with offl ine pCLE images, the in vivo diagnoses showed signifi cantly lower accuracy ( 46 ) . Our HRME diagnoses were made in real-time with the diagnosis of neoplastic or non-neoplastic being made as soon as the probe was placed on the polyp. Another signifi cant advantage to our study was that we had three endoscopists with no prior HRME expertise perform the procedures. Th e majority of recent CLE trials have been performed by a single expert endoscopist, who in some cases had performed greater than 100 prior CLE procedures ( 28 ) . In some cases, the observers who post-hoc analyzed the CLE images had previously assessed over 250 such images ( 26 ) . Although one of our endoscopists was an expert in advanced endoscopic imaging, the other two were general gastroenterologists. Th e other unique aspect to our study was the inclusion of sessile serrated adenomas (SSAs). Th ere were seven SSAs in the 171 polyp study (4 % ) and the average size of these lesions was 9.6 mm. HRME had a sensitivity of 85.7 % and a specifi city of 100 % for classifying SSAs as neoplastic polyps. Given the limited sample size, it is diffi cult to confi dently state the specifi c HRME characteristics for SSAs but SSAs tended to have more distorted glands and a greater epithelial to crypt space ratio compared with hyperplastic polyps, whereas not having the linear crypts or elongated nuclei seen typically in tubular adenomas ( Figure 2 ). Further investigation into the HRME characteristics of SSAs is warranted and being planned. Th ere are multiple potential limitations to our study. Primarily, it is important to recognize that the HRME unit is an experimental system that is not commercially available and that profl avine, the topical contrast agent, is an investigational drug only approved for research purposes. Moreover, although some of the CLE studies selected quality-controlled images for analysis, we did not assess the quality of our HRME images before analysis. Th is was due to the fact that the HRME images were acquired and analyzed in real-time and we believe that this fact further enhances our study as a true in-vivo assessment modality. Despite the potential for suboptimal images, the HRME still produced excellent performance characteristics compared with its quality-controlled predecessors. Another potential limitation of our study protocol was that the same endoscopist who made the WLE diagnosis then proceeded to make the HRME diagnosis on the same polyp. Unlike the offl ine CLE studies, the individual making the HRME read was not blinded to the interpretation of the WLE read. However, the pathologist making the fi nal gold standard diagnosis was blinded to both WLE and HRME reads. Although there was no blinding between the WLE and HRME reads, we believe that this study design is a more clinically relevant representation of how the two modalities could complement each other in real-time.
In conclusion, our in vivo , prospective study demonstrated that HRME can be a very eff ective modality in the diff erentiation of neoplastic from non-neoplastic colorectal polyps. High accuracy of HRME, specifi city, and NPV for neoplastic polyps compared not only to high-defi nition WLE but also to advanced modalities such as NBI and CLE, make it a very attractive complementary tool. A combination of standard white-light colonoscopy for polyp detection and HRME for polyp classifi cation has the potential to allow the endoscopist to determine which lesions can be left in situ , which lesions can be discarded, and which lesions need formal histopathologic analysis . Such a technique could decrease not only procedure times but also the number of polypectomies and the cost of histology. Future studies should include a randomized trial comparing HRME to standard of care for small and diminutive polyps as well as a trial directly comparing HMRE to confocal laser endomicroscopy in eff ort to further validate effi cacy of HRME as a classifi cation modality for colorectal neoplasia.
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Study Highlights
WHAT IS CURRENT KNOWLEDGE
3 Screening with colonoscopy has decreased colorectal cancer incidence and mortality.
3 All polyps are not malignant and do not need to be removed.
3 Current colonoscopy technology cannot differentiate between neoplastic and non-neoplastic polyps.
WHAT IS NEW HERE
3 High-resolution microendoscopy may facilitate the identifi cation of neoplastic colorectal polyps in-vivo.
3 High-resolution microendoscopy is signifi cantly less expensive ( < $ 2,000) than other novel colonoscopic imaging tools.
3 A combination of standard colonoscopy and HRME may allow the endoscopist to determine which polyps can be left in situ , which lesions can be discarded, and which lesions need formal histopathologic analysis.
